Inspire Medical Systems, Inc. (INSP)
61.52
-1.47
(-2.33%)
USD |
NYSE |
Sep 01, 16:00
61.52
0.00 (0.00%)
After-Hours: 20:00
Inspire Medical Systems Research and Development Expense (Annual) : 103.16M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 103.16M |
| December 31, 2024 | 114.13M |
| December 31, 2023 | 116.54M |
| December 31, 2022 | 68.64M |
| December 31, 2021 | 37.35M |
| December 31, 2020 | 26.09M |
| Date | Value |
|---|---|
| December 31, 2019 | 12.84M |
| December 31, 2018 | 7.388M |
| December 31, 2017 | 6.194M |
| December 31, 2016 | 7.091M |
| December 31, 2015 | 7.079M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Intuitive Surgical, Inc. | 1.312B |
| Globus Medical, Inc. | 146.94M |
| Enovis Corp. | 120.33M |
| Inogen, Inc. | 19.18M |
| Solventum Corp. | 727.00M |